期刊文献+

表面增强激光解吸电离飞行时间质谱技术在恶性肿瘤患者焦虑情绪评估中的应用 被引量:1

Application of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry technology in evaluating anxiety in patients with malignant tumors
原文传递
导出
摘要 目的研究恶性肿瘤患者焦虑情绪的发生情况,进一步探讨表面增强激光解吸电离飞行时间质谱(SELDI—TOF—MS,简称SELDI)技术在焦虑情绪评估中的意义。方法选取1000例恶性肿瘤患者作为研究对象,于人院当天进行焦虑自评量表(SAS)评定,次日清晨抽取患者空腹静脉血,分析比较SELDI检测结果与SAS评分结果的差异。结果有效样本为988例。SAS评分为(56.320±9.665)分,SAS评分出现焦虑情绪者454例,焦虑情绪发生率45.95%。SELDI技术检测阳性者470例,焦虑情绪发生率47.57%。以SAS评分为判断焦虑情绪的金标准,SELDI技术的灵敏度、特异度分别为93.17%、91.20%,阳性预测值、阴性预测值分别为90.00%、94.02%,总符合率为92.11%,SAS评分与SELDI丰度值相关,拟合曲线显示上调趋势,相关系数为0.837。结论恶性肿瘤患者焦虑情绪的发生率相对较高,SELDI技术在焦虑情绪的评估方面表现出较高的灵敏度、特异度、总符合率和相关性,可作为客观评估焦虑情绪的一种手段。 Objective To study the occurrence of anxiety in patients with malignant tumor, and in further explore the scientificity and clinical application value of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI) technology in anxiety detection. Methods 1 000 patients with malignant tumor were selected as research objects, the self-rating anxiety scale (SAS) was used to evaluate the anxiety on the first day of admission, the fasting venous blood of patients was taken on the next day morning. The SAS score and SELDI result were compared and analyzed. Results The effective sample number was 988. The SAS score was 56.32-+ 9.665, there were 454 cases of anxiety, the incidence rate of anxiety was 45.95 %. 470 cases were SELDI test positive, and the incidence rate of anxiety was 47.57 %. SAS was used as the gold standard to judge anxiety, the sensitivity and specificity of SELDI technology were 93.17 % and 91.20 %, the positive predictive value and negative predictive value were 90.00 % and 94.02 %, the total coincidence rate was 92.11%. SAS score highly correlated with the abundance of SELDI, the fitting curve showed an up trend, and the correlation coefficient was 0.837. Conclusions The incidence of malignant tumor patients anxiety is relatively high. SELDI technique shows high sensitivity, specificity, total coincidence rate and correlation in anxiety detection, it can be used as an objective evaluation of anxiety.
出处 《肿瘤研究与临床》 CAS 2016年第1期43-47,共5页 Cancer Research and Clinic
基金 山西省回国留学人员科研资助项目(2012093)
关键词 表面增强激光解吸电离飞行时间质谱 恶性肿瘤 焦虑 焦虑自评量表 Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry Malignant tumor Anxiety Self-rating anxiety scale
  • 相关文献

参考文献18

  • 1陈万青,张思维,曾红梅,郑荣寿,邹小农,赵平,吴良有,李光琳,赫捷.中国2010年恶性肿瘤发病与死亡[J].中国肿瘤,2014,23(1):1-10. 被引量:880
  • 2Schofield P, Carey ML, Bonevski B, et al. Barriers to the provision of evidence-based psychosocial care in oncology [ J ] .Psycho Oncol, 2006, 15 ( 10 ) : 863-872.
  • 3刘振静.恶性肿瘤患者情绪障碍的研究进展[J].国际精神病学杂志,2005,32(4):232-236. 被引量:12
  • 4王清馨,姚璧,郑丽君,赵丽华,王鑫,裴毅.一组与焦虑症相关的蛋白质组指纹的研究报告[J].肿瘤研究与临床,2008,20(7):442-444. 被引量:7
  • 5肖雪媛,卫秀平,何大澄.应用蛋白质芯片技术从血清中筛选肺癌标志蛋白[J].中国科学(C辑),2003,33(4):323-328. 被引量:51
  • 6Hebert BR, Harry JI, Packer NH, et al. What place for polyacrylamide in proteomics [ J ]. Trends Biotechnol, 2001, 19 ( 10 ) : S3-9.
  • 7Zeidan BA, Cutress RI, Hastie C, et al. SELDI-TOF MS proteomies in breast cancer [ J ]. Clin Proteomics, 2009, 5 (3) : 133-147.
  • 8Husi H, Stephens N, Cronshaw A, et al. Proteomie analysis of urinary upper gastrointestinal cancer markers [ J ]. Proteomics Clin Appl, 2011, 5 ( 5-6 ) : 289-299.
  • 9Fakelman F, Felix K, Btichler MW, et al. New pre-analytical approach for the deep proteome analysis of sera from pancreatitis and pancreas cancer patients [ J ]. Arch Physiol Biochem, 2010, 116 ( 4- 5 ) : 208-217.
  • 10Smith FM, Gallagher WM, Fox E, et al. Combination of SELDI-TOF- MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy [ J ]. Ann Surg, 2007, 245 ( 2 ) : 259-266.

二级参考文献40

  • 1殷小勇,杨文霞,牛松涛.癌症患者的护理需求[J].中国误诊学杂志,2005,5(8):1527-1528. 被引量:7
  • 2庞安琪,李丕润,缪秀珍.肿瘤患者的心理特点及护理措施[J].中国误诊学杂志,2006,6(4):742-742. 被引量:23
  • 3戚厚兴,张作记,冯学泉,孔凡歧,马丽.冠心病患者焦虑情绪与血清氧化低密度脂蛋白含量的关系[J].中国行为医学科学,2006,15(4):313-315. 被引量:18
  • 4陈明明,张晓华,孙德文,孙志昌.浅谈肿瘤化学治疗的心理护理[J].现代医药卫生,2006,22(22):3505-3505. 被引量:4
  • 5Smith R A, Mettlin C S, Davis K J, et al. American cancer society guidelines for the early detection of cancer. CA Cancer J Clin, 2000, 50(1): 34 -49.
  • 6Bichsel V E, Liotta L A, Petricoin E F, et al. Cancer proteomics: from biomarker discovery to signal pathway profiling.Cancer J, 2001, 7(1): 69 - 78.
  • 7Eggeling F V, Junker K, Fiedler W, et al. Mass spectrometry meets chip technology: A new proteomic tool in cancer research?Electrophoresis, 2001, 22:2898 - 2902.
  • 8Eggeling F V, Davies H, Lomas L, et al. Tissue-specific microdissection coupled with Protein Chip array technologies:applications in cancer research. Biotechniques, 2000, 29(5): 1066 - 1070.
  • 9Paweletz C, Trock B, Pennanen M, et al. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Marker, 2001, 17(4): 301 - 307.
  • 10Vlahou A, Schellhammer P F, Mendrinos S, et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. American Journal of Pathology, 2001, 158(4): 1491 - 1502.

共引文献1062

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部